FDA Label for Genteal Tears (mild)

View Indications, Usage & Precautions

Genteal Tears (mild) Product Label

The following document was submitted to the FDA by the labeler of this product A-s Medication Solutions. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Purpose



Active IngredientsPurpose
Dextran 70 0.1%Lubricant
Hypromellose 2910 0.3%Lubricant

Uses



  • temporary relief of burning and irritation due to dryness of the eye
  • temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun
  • as a protectant against further irritation

Warnings



For external use only


Do Not Use



  • if solution changes color or becomes cloudy
  • if you are sensitive to any ingredient in this product

When Using This Product



  • to avoid contamination, do not touch tip of container to any surface
  • replace cap after using

Otc - Stop Use



Stop use and ask a doctor if you experience any of the following:

  • eye pain
  • changes in vision
  • continued redness or irritation of the eye
  • condition worsens or persists for more than 72 hours

Keep Out Of Reach Of Children.



If swallowed, get medical help or contact a Poison Control Center right away.


Directions



  • put 1 or 2 drops in the affected eye(s) as needed

Other Information



  • store at room temperature

Inactive Ingredients:



POLYQUAD* (polyquaternium-1) 0.001% preservative, potassium chloride, purified water, sodium borate and sodium chloride. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.


How Supplied



Product: 50090-2352

NDC: 50090-2352-0 15 mL in a BOTTLE, DROPPER / 1 in a CARTON


Questions?



In the U.S. call 1-800-757-9195
(Mon-Fri 9AM-5PM CST)
[email protected]


* Please review the disclaimer below.